2m 2m 2m 2m 2m 2m 2m
KYVERNA THERAP (KYTX)
NASDAQ
$5.19+$0.11 (+2.17%)
Price as of Nov 11, 2026 7:30 PM EST- $314.2MMarket Cap
- -27.43%1-Year Change
- BiotechnologyIndustry
KYVERNA THERAP (KYTX)
$5.19+$0.11 (+2.17%)
KYTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $5.08 | ||
Change | -$0.09 (-1.74%) | ||
Open | $5.14 | ||
High | $5.28 | ||
Low | $5.00 | ||
Previous Close | $5.17 | ||
Volume | 472,273 | ||
30-Day Average Volume | 843,132 | ||
1-Week Change | -1.55% | ||
1-Month Change | -20.50% | ||
1-Year Change | -27.43% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 61.8M | ||
Total Assets | $219.8M | ||
Market Cap | $314.2M | ||
Enterprise Value | $307.2M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$38.3M | ||
Free Cash Flow | -$40.3M | ||
EBIT | -$37.6M | ||
EBITDA | -$37.2M | ||
Net Working Capital | $183.7M | ||
EPS | -$0.63 | ||
Enterprise Value/EBITDA | -8 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -8 | ||
PEG | -2 | ||
Price/Free Cash Flow | -8 | ||
Price/Operating Cash Flow | -8 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue